Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Tissue converter Accrol reported narrower first-half losses and said it plans to resume dividend payments this year.
The company also said it was confident full-year results would be at least in line with expectations.
Accrol said it would restore dividend payments earlier than it anticipated, forecasting a proposed final dividend increase of no less than 0.5p per ordinary share for the year ending 30 April 2021.
For the year six months ended 31 October, pre-tax losses narrowed to £0.5 million from £3 million year-on-year even as revenue fell 4.3% to £62.3 million.
The integration of Leicester Tissue Company, acquired in November 2020, for £41.8m, was progressing better than expected, the company said.
'Margins are continuing to improve, and further improvements are expected, generating increasingly strong cash flows and reducing net debt at a faster rate than anticipated,' it added.
Net debt for 30 April 2021 was expected to be below consensus market forecasts of £12.2 million, even after the intended dividend payment, the company said.
At 9:30am: (LON:ACRL) Accrol Group Hldgs Plc share price was 0p at 48.5p